C-MER MEDICAL (03309) spent HK$386,800 to repurchase 218,000 shares on June 16th.
Hema Medical (03309) announced the repurchase of 21.8 million Hong Kong dollars on June 16, 2025.
C-MER MEDICAL (03309) announced that on June 16, 2025, it spent HK$38,668 to buy back 218,000 shares.
Related Articles
US Stock Market Move | Sun Yuchen's Tron will be reverse merged with SRM Entertainment (SRM.US) listed in the United States, and the stock has surged over 300%.
US Stock Market Move | Rare earth sector strengthened, MP Materials (MP.US) surged over 12%.
CHINFMINING (01258) plans to gradually acquire a controlling stake in Kazakh copper company SM Minerals.
US Stock Market Move | Sun Yuchen's Tron will be reverse merged with SRM Entertainment (SRM.US) listed in the United States, and the stock has surged over 300%.
US Stock Market Move | Rare earth sector strengthened, MP Materials (MP.US) surged over 12%.
CHINFMINING (01258) plans to gradually acquire a controlling stake in Kazakh copper company SM Minerals.
RECOMMEND
Vanke Intensifies Self-Rescue Efforts Amid Liquidity Crisis as SZMC Provides Major Support
16/06/2025
Chen Maobo Reaffirms Commitment to Stablecoin Regulation and Digital Asset Development in Hong Kong
16/06/2025
Is a “H+A” Listing Wave Coming to the SZSE? Shenzhen’s Comprehensive Reform Unlocks New Capital Market Pathways
16/06/2025
